The Buffett Rule

[detbuch]

Originally Posted by spence

I'm well aware of the business process regarding FDA regulated product development.

Here's the issue. There's competition for drug prices inside the US but the development is done for a global market. All that R&D funding to create the next category killer drug is being subsidized by US consumers because drugs are sold at lower costs (often via price controls) in pretty much every other nation. There really isn't a lot of real negotiation. This is government regulation that the industry is highly dependent on.

Hence my comment being in context of "market forces".

-spence

When you said that pharma charging "what ever they want" without any negotiation is not yoiur "idea of market forces at work . . ." it seemed on the one hand a contradiction since market forces do not negate charging what you desire so long as the buyer needs your product and is willing and able to pay your price. But pharma's prices are obviously not a result of market forces, so your comment was gratuitus.

Perhaps you are mixing market "forces" with market "economy"? Market "forces" are thos economic factors strictly peculiar to the market without government input, such as supply and demand. Market "economies" are largely driven by market "forces" but may have varying degrees of government intervention. As government control becomes greater, it becomes a mixed economy, and if that control is great or absolute, it is a centrally planned economy where market "forces" play little or no part.

As far as pharma's prices go, they seem to be a product not of market forces, but of more centrally planned forces--both in the U.S. and abroad.

In a "free" market, driven basically by market forces with little to no government intervention, prices would have to go down in the U.S. and up abroad. This would be so even with basic safety regulations, not with the super cautious, draconian ones of present which have massively ballooned since the thalidomide scandal of 1961-62 and have created a cozy, corrupt partnership between pharma and the FDA at the expense of free market competition and "affordable" drugs.

[spence]

Originally Posted by detbuch

When you said that pharma charging "what ever they want" without any negotiation is not yoiur "idea of market forces at work . . ." it seemed on the one hand a contradiction since market forces do not negate charging what you desire so long as the buyer needs your product and is willing and able to pay your price. But pharma's prices are obviously not a result of market forces, so your comment was gratuitus.

Perhaps you are mixing market "forces" with market "economy"? Market "forces" are thos economic factors strictly peculiar to the market without government input, such as supply and demand. Market "economies" are largely driven by market "forces" but may have varying degrees of government intervention. As government control becomes greater, it becomes a mixed economy, and if that control is great or absolute, it is a centrally planned economy where market "forces" play little or no part.

I'd think that government influence (here and abroad) as part of a free market economy would have a large impact on both supply and demand.

As far as pharma's prices go, they seem to be a product not of market forces, but of more centrally planned forces--both in the U.S. and abroad.

In a "free" market, driven basically by market forces with little to no government intervention, prices would have to go down in the U.S. and up abroad.

Today we have regulation that impacts both profit and loss, take away it all away and the results would be unpredictable. Perhaps lower prices from competition but also increased costs if quality standards are not maintained. Undoing a heavily regulated industry is a lot different than pretending it never existed in the first place.

This would be so even with basic safety regulations, not with the super cautious, draconian ones of present which have massively ballooned since the thalidomide scandal of 1961-62 and have created a cozy, corrupt partnership between pharma and the FDA at the expense of free market competition and "affordable" drugs.

I wouldn't say that proving a drug is safe and effective, or that it actually does what you claim it does...is "draconian". This relationship must be pretty unbearable what with all the private sector profit it creates.

-spence

[detbuch]

Originally Posted by spence

I'd think that government influence (here and abroad) as part of a free market economy would have a large impact on both supply and demand.

You're creating a different context here. The original context was pharma charging whatever it wants not being your idea of market "forces." Government influence does not play a part in the traditional usage of the term "market forces". Now your also being loose with "free market." If government regulation on a market is LARGE, it is not, strictly, a "free" market, but a controlled market in either a mixed economy or a centrally planned economy. Hence, your unnecessary remark about pharma's pricing not being your idea of market forces at work. Of course, THEIR PRICING IS NOT A RESULT OF MARKET FORCES, BUT A RESULT GOVERNMENT REGULATION, that is, a result of central planning.

Today we have regulation that impacts both profit and loss, take away it all away and the results would be unpredictable. Perhaps lower prices from competition but also increased costs if quality standards are not maintained. Undoing a heavily regulated industry is a lot different than pretending it never existed in the first place.

The results can be fairly predictable if done right. The result of current conditions is obviously unsustainable. Safe quality standards can be maintained with far less government regulation and, thus, at far less cost, by allowing good manufacturing practice (GMP) certified facilities to produce generic drugs with a warning label that they are not produced under the same standards required for FDA approved generic drugs, etc. This would also help to eliminate the big problem of drug counterfeiting that exists now since it would not be as profitable to produce fakes of cheaper drugs. And it would help to reduce the problem of defective generic drugs produced in China or India. Another way to lower costs is not to ban all other forms of a drug that is granted orphan drug status. These drugs are for rare diseases, and not profitable to produce unless exorbitant prices can be charged.

I wouldn't say that proving a drug is safe and effective, or that it actually does what you claim it does...is "draconian". This relationship must be pretty unbearable what with all the private sector profit it creates.

-spence

When regulation is so expensive that it can bankrupt a country, I would say that it is draconian. Medicare has an unfunded liability of $24.6 trillion (downgraded from $37 trillion in 2009 by fictitious "assumptions" to hide the true liability). That's just Medicare. Not Social Security, the national debt, the military, etc., just Medicare. Subsidizing drugs are a major portion of that liability. And, as you have implied several times, the "relationship" (between the government and pharma) is what sustains the profits that bother you.